Techno Drugs Balance Sheet Health
Financial Health criteria checks 2/6
Techno Drugs has a total shareholder equity of BDT2.6B and total debt of BDT2.7B, which brings its debt-to-equity ratio to 101.7%. Its total assets and total liabilities are BDT6.0B and BDT3.4B respectively. Techno Drugs's EBIT is BDT526.0M making its interest coverage ratio 2. It has cash and short-term investments of BDT87.7M.
Key information
101.7%
Debt to equity ratio
৳2.66b
Debt
| Interest coverage ratio | 2x |
| Cash | ৳87.69m |
| Equity | ৳2.61b |
| Total liabilities | ৳3.43b |
| Total assets | ৳6.04b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TECHNODRUG's short term assets (BDT2.2B) exceed its short term liabilities (BDT2.1B).
Long Term Liabilities: TECHNODRUG's short term assets (BDT2.2B) exceed its long term liabilities (BDT1.3B).
Debt to Equity History and Analysis
Debt Level: TECHNODRUG's net debt to equity ratio (98.4%) is considered high.
Reducing Debt: Insufficient data to determine if TECHNODRUG's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: TECHNODRUG's debt is not well covered by operating cash flow (7.9%).
Interest Coverage: TECHNODRUG's interest payments on its debt are not well covered by EBIT (2x coverage).